Namkung, Yoon http://orcid.org/0000-0002-3085-2066
Le Gouill, Christian
Lukashova, Viktoria
Kobayashi, Hiroyuki http://orcid.org/0000-0003-4965-0883
Hogue, Mireille
Khoury, Etienne
Song, Mideum
Bouvier, Michel http://orcid.org/0000-0003-1128-0100
Laporte, Stéphane A.
Article History
Received: 19 January 2016
Accepted: 8 June 2016
First Online: 11 July 2016
Competing interests
: M.B. is the Chief Executive Officer of a not-for-profit company (IRICoR), whose mission is to promote the commercial transfer of technologies developed by investigators of the Institute for Research in Immunology and Cancer (IRIC) and collaborators. S.A.L and M.B. belong to an academic consortium ‘Groupe Biosenseurs’ that develops BRET-based sensors for studying receptor function. A patent has been filed for the biosensors used herein (62/052,738 19 September 2014, inventors: Y.N., M.B., C.L., V.L., M.H. and S.A.L.), and the use of the technology has been licensed to Domain Therapeutics for commercialization. For academic research, these biosensors can be obtained and used without limitations with a standard academic materials transfer agreement (MTA). The other authors declare that they have no competing interests.